Cargando…

SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods

Evidence suggests that monovalent vaccine formulations are less effective against the Omicron SARS-CoV-2 than against previous variants. In this retrospective cohort study of hospitalized adults with PCR-confirmed COVID-19 during the Delta (October–November 2021) and Omicron (January–April 2022) var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stupica, Daša, Collinet-Adler, Stefan, Kejžar, Nataša, Poljak, Mario, Štamol, Tina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918275/ https://www.ncbi.nlm.nih.gov/pubmed/36769609 http://dx.doi.org/10.3390/jcm12030961

Ejemplares similares

The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance
por: Stupica, Daša, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
por: Filippatos, Filippos, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain
por: Poljak, Mario, et al.
Publicado: (2021)

Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea
por: Lee, Jin, et al.
Publicado: (2023)

Systemic immune responses in patients with early localized or early disseminated Borrelia afzelii lyme borreliosis
por: Cerar Kišek, Tjaša, et al.
Publicado: (2020)

Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021–March 2022
por: Wilson, W. Wyatt, et al.
Publicado: (2023)

SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period
por: Yang, Su Lan, et al.
Publicado: (2022)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Association between statin use and clinical course, microbiologic characteristics, and long-term outcome of early Lyme borreliosis. A post hoc analysis of prospective clinical trials of adult patients with erythema migrans
por: Stupica, Daša, et al.
Publicado: (2021)

Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore
por: Zeng, Kangwei, et al.
Publicado: (2023)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
por: Nersisyan, Stepan, et al.
Publicado: (2022)

Sporadic Hepatitis A Virus PCR False-Positive Results Observed during Reflex Testing of Serum Samples Previously Tested for Anti-HAV Antibodies and Caused by Contamination with HAV RNA Present in the Reagents of the Commercial Anti-HAV Immunoassay
por: Lunar, Maja M., et al.
Publicado: (2023)

The Detection of Periodic Reemergence Events of SARS-CoV-2 Delta Strain in Communities Dominated by Omicron
por: Westcott, Claire E., et al.
Publicado: (2022)

Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2
por: Park, Sang Woo, et al.
Publicado: (2023)

2294. Severity and characteristics of patients hospitalized during Delta and Omicron-predominant COVID-19 time periods in Los Angeles County
por: Greene, Carmon, et al.
Publicado: (2023)

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Mimura, Wataru, et al.
Publicado: (2022)

Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study
por: Sankar, Keerthana, et al.
Publicado: (2023)

Performance of nasopharyngeal swab and saliva in detecting Delta and Omicron SARS‐CoV‐2 variants
por: Uršič, Tina, et al.
Publicado: (2022)

Severity predictors of COVID-19 in SARS-CoV-2 variant, delta and omicron period; single center study
por: Ogawa, Fumihiro, et al.
Publicado: (2022)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022
por: Greene, Sharon K., et al.
Publicado: (2022)

Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants
por: Moghnieh, Rima, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea
por: Choi, Soo-Han, et al.
Publicado: (2023)

Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand
por: Intawong, Kannikar, et al.
Publicado: (2023)

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
por: Sigal, Alex, et al.
Publicado: (2022)

Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients
por: Lina, Liu, et al.
Publicado: (2022)

SARS-CoV-2 Delta–Omicron Recombinant Viruses, United States
por: Lacek, Kristine A., et al.
Publicado: (2022)

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
por: Chaudhari, Armi M., et al.
Publicado: (2022)

Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
por: Bolze, Alexandre, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
por: Montes-González, José Antonio, et al.
Publicado: (2023)

Association between self-reported masking behavior and SARS-CoV-2 infection wanes from Pre-Delta to Omicron-predominant periods — North Carolina COVID-19 Community Research Partnership (NC-CCRP)
por: Tjaden, Ashley H., et al.
Publicado: (2023)

Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan
por: Li, Y., et al.
Publicado: (2023)

Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada
por: Fibke, Chad D., et al.
Publicado: (2022)

1523. Association between Self-reported Masking Behavior and SARS-CoV-2 Infection Wanes from Pre-Delta to Omicron-Predominant Periods — North Carolina COVID-19 Community Research Partnership (NC-CCRP)
por: Tjaden, Ashley H, et al.
Publicado: (2022)

Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
por: Lee, Richard Kuan-Lin, et al.
Publicado: (2022)

Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
por: Dong, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9cd69u6tujlme7hudcmsb1t7uf